The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype
Open Access
- 7 November 2023
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 371, 114609
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1R21AG075008-01 R01CA129769, P30CA51008, R01 AG067258, R01 NS100704, R01AG068193, R21AG072327, R35CA197289, R35CA283926, T32 NS041218, TL1 TR001431)
- Georgetown University
This publication has 82 references indexed in Scilit:
- Astrocyte Senescence as a Component of Alzheimer’s DiseasePLOS ONE, 2012
- APOE genotype alters glial activation and loss of synaptic markers in miceGlia, 2012
- Examination of the expanding pathways for the regulation of p21 expression and activityCellular Signalling, 2010
- p53 Is Preferentially Recruited to the Promoters of Growth Arrest Genes p21 and GADD45 during Replicative Senescence of Normal Human FibroblastsCancer Research, 2006
- Adriamycin‐mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrainJournal of Neurochemistry, 2006
- Contribution of p16INK4aand p21CIP1pathways to induction of premature senescence of human endothelial cells: permissive role of p53American Journal of Physiology-Heart and Circulatory Physiology, 2006
- Gene regulation and DNA damage in the ageing human brainNature, 2004
- Gadd45a contributes to p53 stabilization in response to DNA damageOncogene, 2003
- The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapyPsycho-Oncology, 2003
- p21 Gene Expression Is Modulated by Egr1Journal of Biological Chemistry, 2003